Ameloblastoma secondary prevention

Jump to: navigation, search


Ameloblastoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ameloblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ameloblastoma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ameloblastoma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ameloblastoma secondary prevention

CDC on Ameloblastoma secondary prevention

Ameloblastoma secondary prevention in the news

Blogs on Ameloblastoma secondary prevention

Directions to Hospitals Treating Ameloblastoma

Risk calculators and risk factors for Ameloblastoma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Secondary prevention strategies following ameloblastoma include follow-up examination at regular intervals for at least 10 years.

Secondary Prevention

  • Regular follow-up examination with the physician is very important in managing ameloblastoma.
  • For ameloblastoma patients follow up should occur at regular intervals for at least 10 years.

References


Linked-in.jpg